ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

ClinicalTrials.gov ID: NCT04523220

Public ClinicalTrials.gov record NCT04523220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 9:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel Group, Placebo-controlled, Multi-center Study to Assess the Safety and Tolerability of Monthly Subcutaneous Administrations of a Low and High Dose Cohort of Osocimab to ESRD Patients on Regular Hemodialysis

Study identification

NCT ID
NCT04523220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
704 participants

Conditions and interventions

Interventions

  • BAY1213790 (Osocimab) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2020
Primary completion
Dec 27, 2021
Completion
May 29, 2022
Last update posted
Jul 20, 2023

2020 – 2022

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
North America Research Institute - Azusa Azusa California 91702
Fresenius Kidney Care - Brawley Brawley California 92227
DaVita South Valley Dialysis Encino California 91316
Fresenius Kidney Care - La Mesa La Mesa California 91942
East L.A. Dialysis Center Los Angeles California 90022
Van Buren Dialysis Center Riverside California 92503
Fresenius Kidney Care Kearny Mesa San Diego California 92111
FMC San Ysidro San Diego California 92154
Queen's Dialysis Unit West Covina California 91790
DaVita Greater Waterbury Dialysis Waterbury Connecticut 06708
ARA Plantation Dialysis, LLC Ellenton Florida 34222
ARA Augusta Augusta Georgia 30901
Liberty Dialysis- Caldwell Caldwell Idaho 83605
Fresenius Kidney Care Evergreen Park Evergreen Park Illinois 60805
Fresenius Kidney Care Baton Rouge Mancuso Lane Baton Rouge Louisiana 70808
Fresenius Kidney Care South Dialysis Shreveport Louisiana 71106
ARA Holyoke Dialysis Center Holyoke Massachusetts 01040
Davita Hospital Hill Dialysis Kansas City Missouri 64108
Renal Medicine Associates Albuquerque New Mexico 87109
Durham Nephrology Associates, Pa Durham North Carolina 27704
Waterloo Dialysis Austin Texas 78756
Fresenius North Austin Dialysis Center Austin Texas 78758
Fresenius Kidney Care - Mission Bend (FMCNA #3971) Houston Texas 77083
Fresenius Kidney Care Sugar Land Sugar Land Texas 77479
Liberty Dialysis St. George St. George Utah 84790
DaVita Butler Farm Dialysis Hampton Virginia 23666

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04523220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2023 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04523220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →